Previous Article | Next Article ![]()
Infection and Immunity, July 2007, p. 3531-3538, Vol. 75, No. 7
0019-9567/07/$08.00+0 doi:10.1128/IAI.00122-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Ambroise D. Ahouidi,1,2,
Martine Zilversmit,3
Amy K. Bei,1
Julian Rayner,4
Ousmane Sarr,2
Omar Ndir,2
Dyann F. Wirth,1
Souleymane Mboup,2 and
Manoj T. Duraisingh1,2*
Harvard School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02115,1 Laboratory of Bacteriology and Virology, Le Dantec Hospital, and Laboratory of Parasitology, Faculty of Medicine and Pharmacy, Cheikh Anta Diop University, Dakar BP 7325, Senegal,2 Department of Organismic and Evolutionary Biology, Harvard University, 16 Divinity Avenue, Cambridge, Massachusetts 02138,3 William C. Gorgas Center for Geographic Medicine, 845 19th St. South, University of Alabama, Birmingham, Alabama 352094
Received 24 January 2007/ Returned for modification 23 February 2007/ Accepted 23 April 2007
|
|
|---|
0.58 kb) in the C-terminal region of the PfRh2b gene at a high prevalence in this population. In contrast to findings of earlier studies, we found no associations between specific sequence variants and distinct invasion pathways. Overall these data highlight the importance of region-specific elaborations in PfRh sequence and expression polymorphisms, which has important implications in our understanding of how the malaria parasite responds to polymorphisms in erythrocyte receptors and/or evades the immune system. |
|
|---|
Both laboratory and field isolates of P. falciparum parasites demonstrate a remarkable plasticity in their ability to invade erythrocytes using alternative receptors (2, 7, 12, 15, 19, 21, 22). Genetic and antibody inhibition studies are beginning to elucidate the molecular basis for this phenomenon (7-9, 11, 12, 15, 18, 19, 22, 26, 27, 31). Several of these studies have established that alternative invasion pathway usage is specifically associated with variant expression of the P. falciparum reticulocyte binding protein homolog family (PfRh) (9, 18, 24, 26, 28, 29). These proteins belong to a superfamily of reticulocyte binding protein-like (RBL) proteins, which includes the Py235 family of Plasmodium yoelii and PvRBP proteins of Plasmodium vivax, which are postulated to be involved in the selection of specific host cells (10, 14). Members of the RBL family have been localized to the apical organelles of the invasive merozoite form and are believed to play a role in the apical recognition of the erythrocyte and tight junction formation.
Five PfRh genes have been identified in the 3D7 P. falciparum genome, PfRh1 (also previously published as PfNBP1), PfRh2a (also previously published as PfR2ha and PfNBP2a), PfRh2b (also previously published as PfR2hb and PfNBP2b), PfRh3 (also previously published as PfRH3), and PfRh4 (also previously published as PfRH4) (13, 24, 26, 30, 32); however, PfRh3 is not thought to be expressed as a protein in the asexual stage (30). PfRh1 interacts with an unidentified sialic acid-containing and trypsin-resistant receptor (Y) (26), and genetic evidence suggests that PfRh2b interacts with another undetermined chymotrypsin-sensitive and trypsin-resistant receptor (Z) in a sialic acid-independent manner (9). PfRh2a, which is identical to PfRh2b except for divergence in the small unique C-terminal region (24), has not been shown to define a dominant invasion phenotype. Expression of PfRh proteins in laboratory isolates of P. falciparum is variable, and the majority of parasite lines alternatively express either PfRh1 or PfRh2a and PfRh2b (9, 29, 31). Interestingly, sialic acid dependence of P. falciparum laboratory-cultured lines correlates with the level of PfRh1 expression, resulting from gene amplification, suggesting that the differential expression of PfRh1 or PfRh2a and PfRh2b specifies the use of alternative invasion pathways. Expression of another paralog, PfRh4, has also been associated with a switch to a sialic acid-independent pathway (28). Adding a further layer of complexity, recently Lobo and colleagues identified sequence polymorphisms in PfRh1, PfRh2a, and PfRh2b that were associated with specific invasion phenotypes in field samples from Brazil (17).
Here we report an investigation into the first-cycle invasion phenotypes of P. falciparum strains from Senegal, an area of low endemicity where most patients harbor clonal parasite lines. Although alternative erythrocyte invasion pathways were commonly used by these parasites, several features of the expression and sequence of the PfRh invasion ligands were unusual. Unlike most lab isolates, all the Senegal isolates studied expressed PfRh1, PfRh2a, and PfRh2b simultaneously, and although there was significant sequence polymorphism in these ligands, they did not associate with specific invasion pathways as has been previously reported (17). Furthermore, a C-terminal sequence deletion in PfRh2b previously identified only in a single lab isolate was present in the majority of these field isolates. The implications of these findings for our understanding of the role of variations in PfRh sequence and expression in defining invasion pathways are discussed.
|
|
|---|
5 ml) were collected from consenting patients during September and October 2004, the peak malaria transmission season. Two collection points were established, one in Pikine (Poste de Sante Touba Diacksao) and the other in Thies (Service de Lutte Anti-Parasitaire), approximately 15 and 70 km from Dakar (Senegal), respectively. A total of 54 samples were collected (27 from Thies and 27 from Pikine), placed on ice, and transported immediately to l'Hopital Aristide Le Dantec, Dakar, for analysis. Erythrocyte invasion assays. Invasion assays were carried out as previously described (9). Briefly, erythrocytes (O+, rhesus+) from a single donor were washed three times in phosphate-buffered saline (PBS) and treated with 2-3,6-8-neuraminidase (66 mU), trypsin (1 mg/ml), or chymotrypsin (1 mg/ml) or with a combination of 2-3,6-8-neuraminidase (66 mU) and trypsin (1 mg/ml; Sigma), which prevents invasion, as a negative control. Positive-control erythrocytes were washed in incomplete RPMI. Erythrocytes were placed on a rotating plate in a 37°C incubator for 1 h. Following treatment, erythrocytes were washed two times in PBS and resuspended in complete RPMI (incomplete RPMI supplemented with 5% [vol/vol] O+ and 0.25% [wt/vol] albumax [10 ml]) at a 2% hematocrit (calculated using a Hauser Scientific phase hemacytometer).
Infected samples were adjusted to 1% parasitemia with uninfected erythrocytes and then washed in PBS three times. Samples were then treated with 2-3,6-8-neuraminidase (66 mU; Calbiochem) and trypsin (1 mg/ml; Sigma for 1 h at 37'C) to prevent reinvasion of donor cells, washed two times, and resuspended in complete RPMI at 2% hematocrit.
Treated parasitized erythrocytes (50 µl) were added to treated nonparasitized erythrocytes (50 µl) in 96-well flat-bottom plates in triplicate. Assay plates were placed in a modular incubator chamber (Billups-Rothenberg) with 5% carbon dioxide-1% oxygen and incubated at 37°C until reinvasion occurred, routinely between 48 and 72 h. First-round parasitemias were determined by counting a minimum of 500 erythrocytes using a Miller graticule.
Western blots, PCR mapping, and Southern blots. Parasite culture supernatants were separated on 5% or 10% Tris-glycine polyacrylamide gels and transferred to a nitrocellulose membrane (0.45 µM; Schleicher & Schuell). Membranes were blocked with 10% milk in PBS-Tween 20 before blotting with antisera specific for PfRh1, PfRh2a, and PfRh2b (used at a 1/300 dilution). The specificities of these antibodies have been described previously (26). Protein loading was controlled using mab2F3, specific for Sera5 (used at a 1/1,000 dilution), kindly provided by Brendan Crabb (WEHI). Parasite supernatants have been previously shown to correlate with protein levels in schizonts for PfRh1 in a semiquantitative fashion (31). Differences in PfRh2a and PfRh2b levels previously observed for laboratory isolates in supernatants (9) are also observed in schizonts (see Fig. S1 in the supplemental material).
PCR mapping of the size polymorphism in PfRh2b was carried out using the following primers: P1-GCGGATCCGGTGATGAAAAATTAATATTAAAAG, P2-GCGGATCCCAACAACAAAGAAATATCCAAG, P3-GCGAATTCTTAATCATG TGTACTAGACGTGTTTC, and P4-GCGAATTCATCATCCATTTTGTTATGGTTTG (restriction sites indicated in bold) (see Fig. 4A). PCR typing of either the full-length PfRh2b or PfRh2bdel from the Senegalese isolates was carried out using the primers P2 and P4.
![]() View larger version (38K): [in a new window] |
FIG. 4. Identification of a large sequence polymorphism within the C terminus unique region of PfRh2b in Senegalese isolates. (A) Schematic of PfRh2a and PfRh2b showing the 3' repetitive, unique, transmembrane, and cytoplasmic tail regions. Primers used for the PCR mapping of the deletion are indicated. (B) PCR mapping identifies a major sequence deletion in the unique region of PfRh2b in representative Senegalese isolates. (C) Southern blot of the C-terminal region of PfRh2b, confirming the presence of the deletion in the chromosomal DNA in a subset of Senegalese isolates. A fragment of the unique region upstream of the deletion, amplified with P1 and P3, was used as a probe. (D) The sequence of the PfRh2b deletion is identical in multiple Senegalese isolates and the Thai isolate T996w (T996 obtained from WEHI, Melbourne). Alignment of the unique region from Senegalese isolate with and without the deletion with those of HB3 and T996w.
|
Amplification and sequencing of the polymorphic regions of PfRh1, PfRh2a, and PfRh2b. Gene fragments of PfRh2a and PfRh2b containing both the repeat region and the downstream unique region were amplified for sequencing using a single upstream primer, Rh2F (GTCGATGAAGCTACTTATTT), and separate downstream primers, Rh2aR (CCTGTGTGTATATAGCAAC) and Rh2bR (ATCATCCATTTTGTTATGGTTTG). A region surrounding the PfRh1 gene was amplified using the primers Rh1F (CATAATCATAATCATAATCATAATC) and Rh1R (CAAAAATACATTCTTTCATGGTTTCC). PCR primers were used for sequencing as well as internal primers Rh2a internal F (GAAAGAAAGAAAATCGAGTTAG), Rh2a internal R (CTAACTCGATTTTCTTTCTTTC), Rh2b internal F (TGCGTATGATCATGTTGTTT), and Rh2b internal R (AGCATCACGTTGGTCAGTA). Gene fragments were amplified with PCR using HotStarTaq DNA master mix (QIAGEN) on a DNA Engine Tetrad thermal cycler (MJ Research). PCR products were purified for direct sequencing using ExoSap-IT (US Biochemicals Corporation) and sequenced on an ABI3100 or ABI3730 capillary sequencer using BigDye Terminator v.3.0 (Applied Biosystems, CA) chemistry. Sequences were edited using Sequencher v.4.2.2 software (Gene Codes Corporation) and aligned manually using MacClade v.4.06.
|
|
|---|
![]() View larger version (17K): [in a new window] |
FIG. 1. Plasmodium falciparum strains from Dakar, Senegal, routinely use alternate erythrocyte invasion pathways. (A) Efficiency of invasion by P. falciparum of neuraminidase (Nm)-treated erythrocytes, chymotrypsin (Chymo)-treated erythrocytes, and trypsin (Tryp)-treated erythrocytes. (B) Lack of significant correlation of efficiencies of invasion of enzyme-treated erythrocytes for the series of isolates. Rs and P values were derived by Spearman's rank correlation.
|
Minimal variation in levels of expression of PfRh1, PfRh2a, and PfRh2b in Senegalese P. falciparum strains. Protein expression of the PfRh ligands PfRh1, PfRh2a, and PfRh2b is variant in most laboratory-adapted P. falciparum strainsthose that express PfRh1 often do not express detectable levels of PfRh2a and PfRh2b, while those that express PfRh2a and PfRh2b often express undetectable levels of PfRh1 (29, 31). We were interested in examining the extent of alternate expression of the different PfRh paralogs in the Senegalese isolates. To determine whether similar patterns of expression are observed with our field isolates, we probed parasite supernatants on Western blots with antibodies specific for PfRh1, PfRh2a, and PfRh2b (24, 26). Unlike the case with the majority of laboratory isolates, we found that all Senegalese P. falciparum field isolates tested expressed PfRh2a and PfRh2b, while almost all expressed PfRh1 (Fig. 2). We were not able to assess PfRh4 expression due to the unavailability of a specific antibody that recognizes PfRh4 in culture supernatants.
![]() View larger version (24K): [in a new window] |
FIG. 2. P. falciparum isolates from Senegal exhibit minimal variation in the expression of PfRh1, PfRh2a, and PfRh2b. Western blots of supernatant extracts probed with antisera specific for PfRh2a, PfRh2b, PfRh1, or PfSera5 as a loading control. The various sizes of PfRh2a and PfRh2b in the different isolates result from both sequence polymorphisms in the repetitive regions of these proteins and proteolytic breakdown products that are commonly observed even in laboratory isolates. Additionally, some isolates contain a large sequence deletion in PfRh2b (indicated by an arrow).
|
![]() View larger version (25K): [in a new window] |
FIG. 3. Lack of PfRh1 amplification in Senegalese field isolates. Southern blot to determine PfRh1 copy number. Pfdhps is a single-copy gene used as a control. PfRh1 copy number was determined for each sample by comparing the Pfdhps/PfRh1 signal ratio for each Senegalese isolate to that for HB3, which is known to have a PfRh1 copy number of 1.
|
The sequence encoding the C-terminal region of PfRh2b was determined for 17 Senegalese isolates. Five of the 17 isolates contained the wild-type sequence for PfRh2b, while 12 isolates showed a single identical 582-bp deletion in the sequence, PfRh2bdel, corresponding to the amino acid residues 2867 (D) to 3061 (L), in the predicted protein sequence for full-length PfRh2b (MAL13P1.176) (Fig. 4D). No other polymorphisms were found within this region. The PfRh2bdel sequence is similar but not identical to one previously identified by Taylor and colleagues in the laboratory-adapted parasite line T996 from Thailand, differing only by a single point mutation at the boundary (29). However, resequencing of the T996 allele (provided by Tony Triglia, WEHI) revealed a sequence identical to that observed in the Senegalese samples.
We investigated the possibility that PfRh2bdel polymorphism is associated with the use of neuraminidase-sensitive invasion pathways. A positive association of borderline significance was found (P = 0.062, two-tailed Mann-Whitney U test) (Fig. 5A). No difference in the use of chymotrypsin-sensitive pathways was observed between the two groups.
![]() View larger version (25K): [in a new window] |
FIG. 5. The role of the PfRh2bdel polymorphism in the Senegalese isolates. (A) Association between invasion pathway utilization and the presence of the PfRh2bdel polymorphism. P value indicated was derived using a Mann-Whitney U test. DEL, deletion present; FULL, full-length sequence; NS, not significant. (B) PCR assay for the identification of polymorphisms in the downstream deletion in PfRh2b. (C) High prevalence of PfRh2b deletion in Senegalese population, determined using the PCR-based assay for the detection of the PfRh2bdel in isolates from Pikine (n = 23) or Thies (n = 19).
|
Polymorphism in the repeat regions of PfRh1, PfRh2a, and PfRh2b. Recently, Lobo and colleagues identified polymorphisms in repeat regions of PfRh1, PfRh2a, and PfRh2b that were associated with specific invasion pathways in Brazil (17). We sequenced the regions of the corresponding genes containing these polymorphisms to assess whether similar associations could be found in parasites from Senegal.
For PfRh1, we found that there is significant polymorphism in the repetitive region (Fig. 6). Three parasites of the 15 successfully sequenced had the FFS-like 10D variant (using the coding system of Lobo and colleagues [15]), previously reported to be associated with a sialic acid-dependent and trypsin-resistant invasion pathway in Brazil, while 5 isolates contained the 3D7-like 10D* variant and one the RPN-like 6D variant. Three novel variants, 8D (NOVEL A), 8D* (NOVEL B), and 12D (NOVEL C), were also found. Therefore, 6 different variants were identified from 16 determined sequences, demonstrating the complexity of this repeat region.
![]() View larger version (22K): [in a new window] |
FIG. 6. Extensive and novel polymorphisms in the repetitive regions of PfRh1, PfRh2a, and PfRh2b. (A) Alignment of PfRh1 repetitive sequence polymorphisms and their allelic designations according to the convention of Lobo et al. (17) (amino acids 2734 to 2741 according to the 3D7 sequence, accession no. AAQ10315). Isolates that contain polymorphisms previously described by Lobo et al. (17): 3D7-LIKE (P18, T14, and T15); FFS-LIKE (P04, P06, T04, T09, and T10); Dd2-LIKE (T22). Isolates that contain novel polymorphisms: NOVEL A (T11, T18, P02, P12, and T13); NOVEL B (P15), and NOVEL C (P09). (B) Alignment of sequence polymorphisms in the repetitive regions of PfRh2a in multiple Senegalese isolates. Polymorphism in the repetitive regions and the "pep" polymorphisms (amino acids 2734 to 2741 according to the FVO sequence, accession no. AAN39446) are indicated in bold. Isolates that contain polymorphisms previously described by Lobo et al. (17), FVO-LIKE (P04, P05, P06, P12, P41, P43, T09, T10, T11, and T13). Isolates that contain novel polymorphisms, NOVEL A (P15 and T15), NOVEL B (P18), and NOVEL C (T14). (C) Alignment of sequence polymorphisms in the repetitive regions of PfRh2b in multiple Senegalese isolates. The repetitive region and "pep" polymorphisms (amino acids 2769 to 2777 according to the 3D7 sequence, accession no. AAN39447) are indicated in bold. Isolates that contain polymorphisms previously described by Lobo et al. (17): 3D7-LIKE (P04,P05,P41,P43,T09,T10,T12,T13,T14,T18) and GVM-LIKE (P06,P15,P18,T22). Isolates that contain novel polymorphisms: NOVEL A (P09), NOVEL B (T11), and NOVEL C (P12). Isolates containing the downstream PfRh2bdel polymorphism are shown in bold.
|
The "pepC*" peptide sequence (QKEEELRKK) of PfRh2b was found in the majority of the Senegalese isolates (16/17) (Fig. 6C), while the remaining isolate (P12) contained a novel KKEEELRKK sequence (pepC**). The upstream repeat region was of two major types: the canonical sequence found in the 3D7 parasite line (10/17 isolates) and a 52-amino-acid sequence deletion found in Dd2 and FVO (5/17 isolates) (24) and the majority of Brazilian isolates, including GVM (17). Only two isolates (NOVEL A and NOVEL B) contained smaller deletions of 8 amino acids and 36 amino acids in the repeat regions that appear to be hybrids of the two forms.
No polymorphisms were observed in the unique regions downstream of the PfRh2a and PfRh2b repetitive regions, other than the PfRh2bdel sequence.
Associations between sequence polymorphisms of PfRh paralogs and invasion pathways. The PfRh1 10D polymorphism has been associated with invasion of erythrocytes via neuraminidase-sensitive and trypsin-resistant receptors by Brazilian isolates (17). However, no association was found between this allele and erythrocyte invasion using either the neuraminidase-sensitive or chymotrypsin-sensitive pathway in these Senegalese isolates. The sensitivity of the isolates to trypsin precluded this analysis.
Similarly, the pepB sequences of PfRh2a and PfRh2b were found to associate with the neuraminidase-sensitive and trypsin-resistant pathway in the Brazilian isolates. None of the Senegalese isolates we studied contained the pepB sequences, consistent with the fact that they are largely dependent on trypsin-sensitive receptors for invasion but not consistent with their variable dependency on sialic acid receptors (Fig. 1A). No element in either the PfRh2a or the PfRh2b repetitive regions correlated with invasion pathway usage.
When we considered associations between the different sequence polymorphisms, a weak association was found between the presence of the canonical repeat region sequence in PfRh2b (found in 3D7) and the presence of the downstream PfRh2b deletion (P = 0.056, Fisher's exact; n = 20). This could be due either to a functional interaction between these regions in the PfRh2b protein or alternatively simply to genetic linkage.
|
|
|---|
194-amino-acid deletion in the C-terminal ectodomain region of Rh2b, previously identified only in a single laboratory isolate, which exists at a high prevalence in Senegalese isolates. Our understanding of the extent of alternative invasion pathway usage in isolates of P. falciparum that actually infect people is still limited to a very few locations globally (2, 15, 17, 20, 21). We measured first-round invasion because of the possibility that invasion pathways may be altered in culture-adapted lines due to altered selection pressures in in vitro culture. Under these conditions and even though our study area is an area of low transmission with a large proportion of clonal isolates, we found the extensive utilization of alternative invasion pathways. In particular, there was significant variability in the abilities of these lines to use two independent alternative invasion pathways, sensitivity to neuraminidase or chymotrypsin, respectively. Taken together with the results of previous studies (2, 15, 21), our results emphasize that invasion pathway variation appears to be the norm for uncultured field isolates regardless of their origin. However, all isolates were highly dependent on trypsin-sensitive receptors, mirroring previous observations made with isolates from The Gambia (2). This may be a result of dependence of these isolates on glycophorin A for invasion, as previously suggested (2). However, several other trypsin-sensitive receptors, such as glycophorin C and receptor X, that may also play a role have been identified (7, 16, 18). Although invasion pathway variation is therefore widespread, some pathways are clearly more commonly used in specific regions than others, perhaps reflecting different distributions of erythrocyte surface polymorphisms in the exposed human population.
Alternative invasion pathways are known to be specified in part by the expression and sequence of the P. falciparum RBL invasion ligands PfRh1, PfRh2a, and PfRh2b. Previous studies with laboratory isolates from different parts of the world found that most isolates express either PfRh1 or PfRh2a and PfRh2b (9, 29, 31). Expression of PfRh1 has been associated with sialic acid-dependent invasion, while expression of PfRh2a and PfRh2b has been associated with sialic acid-independent invasion. Differential expression of either PfRh1 or PfRh2a and PfRh2b has also been seen in the only field studies to look at PfRh expression, in Kenya and Tanzania (3, 20). Surprisingly, the dramatic variation in expression of PfRh1 and PfRh2a/PfRh2b seen in laboratory isolates and previous field studies was not a feature of parasites obtained within this population, since almost all field isolates studied in Senegal expressed PfRh1, PfRh2a, and PfRh2b. This was reinforced by the striking absence of PfRh1 gene amplification in this population, which was previously associated with sialic-acid-dependent invasion in a series of laboratory isolates (31). Previous assumptions that differential expression of either PfRh1 or PRh2a and PfRh2b and/or gene amplification is a common feature of parasites using alternate invasion pathways clearly need to be qualified as a result of these studies. Further, a model has been put forth that suggests that expression alone does not dictate the dominant invasion pathway that is utilized by a parasite line for invasion (1). There is likely a hierarchy of molecular interactions, where even though some molecules are expressed, they may not be able to form definitive molecular interactions. This may partly explain the observed lack of association between the expression of the PfRh paralogs and invasion pathway usage.
Indeed, there are many members of the erythrocyte-binding antigen (EBA) and PfRh invasion ligand families that may be able to contribute to alternative invasion pathways in P. falciparum. The relationship between members of the EBA and Rh families is not clear. The targeted deletion of EBA-175 leads to an increase in PfRh4 expression (28). Similarly, in a parasite line with a targeted deletion of PfRh2b, there is an increased dependence on EBA-140 and EBA-175 for invasion (1). Therefore, the EBA and PfRh ligands exhibit a degree of functional equivalence. Expression levels of PfRh4 have been shown to be associated with alternative invasion pathways (28), although it was not possible to assess the expression of PfRh4 in these isolates, and this will be an important feature of future studies. It will also be of interest to determine whether different merozoites within schizonts express different PfRh paralogs, as observed for the rodent malaria parasite Plasmodium yoelii (23).
By contrast, the high prevalence of certain sequence polymorphisms observed in PfRh1, PfRh2a, and PfRh2b in the Senegalese parasites suggests that these polymorphisms may be of greater significance in defining alternative invasion pathways than the variant expression of the PfRh proteins, at least in this population. Many of the sequence polymorphisms have previously been found in globally diverse isolates (17). We found that the most prevalent polymorphisms in the repeat regions of PfRh1, PfRh2a, and PfRh2b in isolates from Brazil were also the most prevalent ones found in Senegal: the 10D/10D* polymorphisms in PfRh1, the pepC polymorphism in PfRh2a, and pepC* in PfRh2b. However, although specific polymorphisms in PfRh1, PfRh2a, and PfRh2b have previously been identified as associating with sialic acid-dependent and trypsin-resistant invasion pathways for Brazilian isolates (17), we were unable to find similar associations for our Senegalese isolates. This highlights the importance of studying these polymorphisms in different regions and suggests that the association of specific PfRh polymorphisms with invasion pathways may be more complex than previously thought. Nevertheless, nothing is known about the precise functional domains of the PfRh proteins. It is possible that these polymorphisms lie in the actual erythrocyte-binding region. Alternatively, they may result from selection for immune evasion.
Size polymorphisms in the repeat regions of PfRh2a and PfRh2b are likely to result from recombination between the repeats shared by both genes. Mitotic recombination between PfRh2a and PfRh2b has already been observed in a long-term-cultured isolate, highlighting the recombination potential of this region (6), and gene conversion between PfRh2a and PfRh2b has been suggested as a mechanism for maintaining the unusual shared structure of these two closely linked genes (25). Even though the prevalence of several PfRh2a and PfRh2b variants is high in Senegal, it is interesting to note that very few of the variants are unique to this region. The presence of the same repeat-region polymorphisms in isolates from Senegal and throughout the world suggests a degree of stability in these alleles through time and geography and that the recombination events that generate novel alleles are not frequent. Alternatively, it is possible that the limited number of novel variants reflects functional constraints on this region.
Downstream of the repeat region in PfRh2a and PfRh2b is a C-terminal ectodomain region that is divergent between them (Fig. 4A). Previously, we found through the use of genetic knockouts that PfRh2b but not PfRh2a is required for a discrete invasion pathway, providing genetic evidence that the difference in function of PfRh2a and PfRh2b maps to this unique region (9). A major finding of this study is the presence of a large deletion in the unique region of PfRh2b that is present at a high prevalence in Senegal. A similar deletion had previously been found in a single lab strain originally isolated from Thailand (T996 or Tak996 isolate) (29). We have also observed this deletion at a high prevalence in different populations throughout Senegal and Africa (Ahouidi et al., unpublished data), and the majority of Senegalese isolates had this deletion. Although the functional implications of this common mutation are currently unknown, here we provide some evidence that it is associated with a sialic acid-dependent invasion pathway (P = 0.062), further emphasizing that PfRh mutations can be associated with the use of alternative invasion pathways. Functional studies using reverse-genetics approaches are under way to confirm this association. If true, this is consistent with a model where the sialic acid-independent ligand PfRh2b harboring the deletion is nonfunctional, allowing the sialic acid-dependent ligand PfRh1 to play a more dominant role.
The PfRh proteins are exposed on the surface of the merozoite, where they can be inhibited by antibodies. In addition to different levels of expression of the PfRh proteins, sequence polymorphisms are likely to play a major role either in altering the specificity of parasite ligands for erythrocyte receptors and/or as a means for immune evasion. These studies emphasize the complexity of the association of PfRh expression and polymorphism profiles with alternative invasion pathways and suggest that we are still some way from being able to draw clear correlations. Further studies, both using field isolates from diverse locations and using reverse-genetics approaches in the laboratory, will make these correlations more clear and define their potential role in clinical severity.
This work was supported by a Fogarty International training grant, 5D43TW001503. M.T.D. was supported by NIH R01AI057919.
Published ahead of print on 30 April 2007. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
These authors contributed equally to this work. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»